Chronic L-DOPA treatment increases extracellular glutamate levels and GLT1 expression in the basal ganglia in a rat model of Parkinson's disease

The European Journal of Neuroscience
S RobeletL Kerkerian-Le Goff

Abstract

There is growing experimental evidence for the implication of glutamate-mediated mechanisms both in the pathophysiology of Parkinson's disease and in the development of dyskinesias with long-term administration of L-3,4-dihydroxyphenylalanine (L-DOPA). However, the impact of this treatment on glutamate transmission in the basal ganglia has been poorly investigated. In this study, we examined the effects of 6-hydroxydopamine-induced lesion of nigral dopamine neurons with or without subsequent chronic L-DOPA treatment on several parameters of glutamate system function in the rat striatum and substantia nigra pars reticulata. All the lesioned animals treated with L-DOPA developed severe dyskinesias. Extracellular glutamate levels, measured by microdialysis in freely moving conditions, and gene expression of the glial glutamate transporter GLT1, assessed by in situ hybridization, were unaffected by dopamine lesion or L-DOPA treatment alone, but were both markedly increased on the lesion side of rats with subsequent L-DOPA treatment. No change in the expression of the vesicular glutamate transporters vGluT1 and vGluT2 was measured in striatum. These data show that chronic L-DOPA treatment leading to dyskinesias increases basal level...Continue Reading

References

Apr 1, 1987·Journal of Neurochemistry·L KerkerianA Nieoullon
Oct 1, 1986·Physiology & Behavior·J P Kroon, A L Riley
Apr 1, 1993·Brain : a Journal of Neurology·P CalabresiG Bernardi
Nov 5, 1997·Synapse·W Timmerman, B H Westerink
Jan 1, 1999·Amino Acids·W J Schmidt
Jul 21, 1999·Proceedings of the National Academy of Sciences of the United States of America·D JabaudonU Gerber
Oct 29, 2000·Trends in Neurosciences·E C HirschY Agid
May 23, 2001·Progress in Neurobiology·N C Danbolt
Feb 21, 2002·Progress in Neuro-psychopharmacology & Biological Psychiatry·Frédéric CalonThérèse Di Paolo
Sep 10, 2002·Parkinsonism & Related Disorders·Frédéric Calon, Thérèse Di Paolo
Oct 12, 2002·Science·Jia LuoMatthew J During
Feb 26, 2003·European Journal of Pharmacology·Claudia CorsiFelicita Pedata
Apr 1, 2003·Nature Neuroscience·Barbara PicconiPaolo Calabresi
May 20, 2003·Biological Chemistry·Ralf Dringen, Johannes Hirrlinger

❮ Previous
Next ❯

Citations

Dec 1, 2012·Journal of Neural Transmission·Dénes ZádoriLászló Vécsei
Aug 18, 2009·Journal of Molecular Neuroscience : MN·Veronica I BritoEva Küppers
Mar 5, 2011·Brain : a Journal of Neurology·Imtiaz AhmedDavid J Brooks
Apr 10, 2009·The Journal of Pharmacology and Experimental Therapeutics·Daniella RylanderM Angela Cenci
Aug 30, 2008·Zhurnal evoliutsionnoĭ biokhimii i fiziologii·L S NikitinaE V Chernigovskaia
Oct 9, 2012·The Journal of Clinical Investigation·Gregory PorrasErwan Bezard
Feb 8, 2013·PloS One·Nina NevalainenIngrid Strömberg
Mar 20, 2014·Neurodegenerative Disease Management·Zsófia Majláth, László Vécsei
May 3, 2011·Expert Opinion on Drug Discovery·Altaf S DarveshCornelis J Van der Schyf
Sep 1, 2006·Journal of Neurochemistry·M Angela Cenci, Martin Lundblad
May 27, 2015·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·Mariza BortolanzaElaine Del-Bel
Jun 21, 2017·Movement Disorders : Official Journal of the Movement Disorder Society·Tanya ChotibutMichael F Salvatore
Mar 6, 2007·NMR in Biomedicine·Nils KicklerPierre Pollak
Oct 2, 2007·NMR in Biomedicine·H Randall GriffithJan A den Hollander
Feb 6, 2010·Journal of Neurochemistry·Bazoumana OuattaraThérèse Di Paolo
Jul 28, 2010·NMR in Biomedicine·Carine ChassainFranck Durif
Oct 29, 2005·Journal of Neuropathology and Experimental Neurology·Véronique Sgambato-FaureFrançois Berger

❮ Previous
Next ❯

Related Concepts

Related Feeds

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.

Basal ganglia in Parkinson's disease (MDS)

The basal ganglia is comprised of the neostriatum, the external and internal pallidal segments, the subthalamic nucleus, the substantia nigra pars reticulata, and the pars compacta of the substantia nigra. The basal ganglia circuitry is responsible for the correct execution of voluntary movements and is implicated in Parkinson's disease. Here is the latest research investigating the basal ganglia in Parkinson's disease.

Astrocytes in Parkinson Disease

Parkinson's disease (PD) is a neurodegenerative disorder caused by the progressive loss of dopaminergic neurons. Some PD-genes may be associated with astrocyte dysfunction. Discover the latest research on astrocytes in Parkinson's disease here.

Astrocytes

Astrocytes are glial cells that support the blood-brain barrier, facilitate neurotransmission, provide nutrients to neurons, and help repair damaged nervous tissues. Here is the latest research.